Describir: Additional Practice-informing Adverse Event Patterns and Management in the KRYSTAL-1 Phase 2 Study of Adagrasib (MRTX849) in Patients With KRASG12C-mutated Non--Small Cell Lung Cancer...Academy of Oncology Nurse & Patient Navigators (AONN+) 14th Annual Navigation & Survivorship Conference, November 15–19, 2023, San Antonio, Texas.